A carregar...
Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma
Immunostimulatory therapies have been a cornerstone of treatment for metastatic renal cell carcinoma (RCC) since the 1990s. However, the use of traditional immunotherapeutic approaches for RCC, such as high-dose interleukin-2 and interferon-α, has been limited by significant systemic toxicities and...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4647139/ https://ncbi.nlm.nih.gov/pubmed/26622321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215597647 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|